{
    "Title": "Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease",
    "URL": "https://doi.org/10.1371/journal.pntd.0007511",
    "Published": "July 3, 2019",
    "Subject_Areas": [
        "Vaccines",
        "Throat",
        "Streptococcus pyogenes",
        "Opsonization",
        "Pharyngitis",
        "Blood",
        "Skin infections",
        "Skin anatomy"
    ],
    "Authors": {
        "Philip M. Giffard": [
            "Menzies School of Health Research, Division of Global and Tropical Health, Darwin, Australia",
            "College of Health and Human Sciences, Charles Darwin University, Darwin, Australia"
        ],
        "Steven Y. C. Tong": [
            "Menzies School of Health Research, Division of Global and Tropical Health, Darwin, Australia",
            "Victorian Infectious Disease Service, The Royal Melbourne Hospital, and Doherty Department University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"
        ],
        "Deborah C. Holt": [
            "Menzies School of Health Research, Division of Global and Tropical Health, Darwin, Australia",
            "College of Health and Human Sciences, Charles Darwin University, Darwin, Australia"
        ],
        "Anna P. Ralph": [
            "Menzies School of Health Research, Division of Global and Tropical Health, Darwin, Australia",
            "Division of Medicine, Royal Darwin Hospital, Darwin, Australia"
        ],
        "Bart J. Currie": [
            "Menzies School of Health Research, Division of Global and Tropical Health, Darwin, Australia",
            "Division of Medicine, Royal Darwin Hospital, Darwin, Australia"
        ]
    }
}